UK life sciences plan aims to quadruple commercial clinical drug trial participation

Package also includes overhauling regulatory process for new medicines and funding for UK Biobank

The government is aiming to quadruple the number of patients taking part in commercial clinical trials in the next four years as part of an ambitious plan to boost UK life sciences.

Unveiling a package of measures for the sector, the chancellor, Jeremy Hunt, said patients would get quicker access to new medicines and the government would cut the bureaucratic burden of approving clinical trials, which has been blamed for a rapid decline in NHS-based trials for cancer and Alzheimer’s drugs. Other measures announced include funding for an upgrade of the UK Biobank and details of a proposed train route between Oxford and Cambridge.

Continue reading…

Notify of
Inline Feedbacks
View all comments